Background: Although previous studies have found physical activity to be associated with lower mortality, the dose-response relation remains unclear. In this systematic review and meta-analysis we quantify the dose response relation of non-vigorous physical activity on allcause mortality.
1-2 Nevertheless, the expected benefit of different amounts of physical activity on all-cause mortality remains unclear. Many cohort studies have estimated a dose response but these have varied in their size, precision and findings, while some suggest a linear relationship with increasing activity, other suggest no additional benefit from higher doses. [3] [4] [5] [6] We aimed to quantify and characterise the nature of the association between non-vigorous physical activity and allcause mortality. 7 Active travel is frequently recommended as a way to increase physical activity; and walking is the most popular form of physical activity.
1 Therefore, in addition to studies looking at multiple aspects of non-vigorous activity we looked for studies that estimated the exclusive effect of walking or cycling on all-cause mortality. Furthermore we investigated if there was a difference in effect according to different gender, age, the quality of the study and the extent of adjustment for potentially intermediary variables.
Methods

Selection criteria
Inclusion criteria were 1) prospective cohort study in a healthy/general population with more than 10,000 people at baseline; 2) measure of light or moderate physical activity (either in terms of duration, frequency, distance or a combination); 3) association with all cause mortality. We excluded studies that only measured work related activity. We only included studies of physical activity not physical fitness. We only included studies that compared more than two exposure levels.
Search strategy
We searched Medline, Embase, Cochrane (DARE), Web of Science, Global Health (in July 2008 and then an update in June 2009), for cohort studies. No time period restrictions were included. Key words used in Medline included, "physical activity", "bicycling", "walking", "exercise", "active travel", "active commuting", "active transport", in combination with "mortality", "life expectancy" and "death". See "On line Appendix: Search strategy". Mesh headings included, "Exercise", "Exercise Therapy", "Physical Fitness", and "Exertion". We searched the reference lists of included studies and other systematic reviews. We also contacted authors of all studies with over 10,000 participants identified as of February 2009 for unpublished studies. All remaining references were assessed by two independent reviewers (JW and OHF) and any disagreements resolved by discussion and mutual agreement. No language restrictions were employed.
Data extraction
We used a data collection form designed before the search for studies took place. We collected information on participants and study characteristics (including age, sex, setting and follow up); measurement of exposure (including domain, restrictions on intensity or duration of activity, physical activity instrument tool and whether this used a questionnaire or interview); ascertainment of outcome; study exclusion criteria and adjustment for potential confounders (e.g. smoking, education); and estimate of treatment effect (the estimate most adjusted for potential confounders).
If a study produced multiple estimates based on different kinds of physical activity we selected the estimate most relevant to non-vigorous activities of daily living, rather than activity done as exercise. If the study also presented results for a group undertaking vigorous activity we ignored this group but included other results from the study, even if this reduced the sample size to fewer than 10,000 people. For secondary analyses we selected estimates exclusively of walking or cycling. If multiple publications were available on the same cohort we chose the most recent publication that met all other inclusion criteria. Some analyses exclude deaths that occur soon after measurement of baseline data to reduce the risk of reverse causation. If available we took the results for the full time period but in the sensitivity analysis we considered studies excluding a time period.
We extracted available data on the duration and intensity of physical activity per week, combining both intensity and duration of activity. The intensity of activities can be categorised according to subjective exertion or with a fixed measure for each activity, usually measured as METs (Metabolic Equivalent Tasks). A MET is a unit of energy expenditure adjusted for mass, with the reference category of 1 MET being the typical energy expenditure of an individual at rest, (4.18 kilojoules/kilogram/hour). 8 Activities below 6 METs are generally defined as moderate and those below 3 METs as light for adults under 65 years. 2 The intensity of selected activities were based on the compendium of physical activities from Ainsworth 2000. 8 We did not include study results based on activities of greater intensity than 6 METs. Time spent in activities of different intensity over a week can be combined to give an estimate of total MET hours per week. The measure of MET hours per week incorporates both the intensity and the total time per week spent on physical activity.
Quality assessment
We assessed the quality of the studies using the Newcastle Ottawa Scale. 9 In this scale studies are assessed in three areas: the selection of exposed and unexposed participants, the comparability of the groups, and the assessment of the outcome. A star is awarded for high quality in each area. The Newcastle Ottawa Scale requires selection of a confounder considered to be the most important and in this case, because of its strong association with mortality 10 , we selected smoking.
Analysis
We pooled the studies using two stage random effects dose-response meta-regression models developed by Greenland and Longnecker as implemented by Orsini and colleagues. This method allows estimation of the dose response gradient of mortality risk across studies taking into account non-independent relative risks presented within a single study. For each study we assigned the midpoint of each exposure interval as the median dose corresponding to the relative risk. If the highest exposure interval was defined as greater than a given value we imputed the median exposure for that interval by assuming a linear decline in the population density function (the number of people in each exposure interval divided by the width of the exposure interval) with increasing exposure. The population density function at the start of the highest exposure interval was estimated based on the population density function for the lower exposure interval.
We converted exposure measures from each study into MET hours of activity per week using the data available in the report and by selecting the estimate from the compendium of activities 8 that appeared most applicable. If an exposure interval could either represent a given duration of moderate intensity physical activity or a shorter duration of more intensive physical activity we assumed the exposure was based on the longer duration of moderate intensity physical activity. If activity was represented as a number of sessions an average duration of 0.5 hours per session was assumed. For estimates that included MET hours spent in sedentary activities we assumed a minimum level of activity in the lowest group based on the data available and calibrated all other estimates to this. If the reference category was high activity we used the method suggested by Hamling 13 to convert the reference category to the lowest exposure category. If information on person-years of follow-up and deaths per group were not provided we decided to impute these based on the study size, length of follow up and differing mortality rates. Statistical heterogeneity among studies included in the meta-analysis was assessed using the Q statistic and I-squared.
14 Small study effects were assessed by the Egger's regression asymmetry test 15 and by visual inspection of a funnel plot.
Assessment of non-linear dose-response relationships
We investigated potential departure from linearity between physical activity and mortality by using first-degree fractional polynomials with different power transformations (0.25, 0.375, 0.50, 0.75) and a log transformation of the exposure (MET hours per week). 16 We used the Akaike's information criterion (AIC, a summary measure that combine fit and complexity) to choose the model that best (lowest AIC value) fitted the data.
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Sensitivity and Stratified Analyses
We pre-specified five subgroup/sensitivity analyses: (i) studies that provided an estimate based on walking alone and, (ii) studies that provided an estimate on cycling alone. We looked (iii) at the extent to which the study controlled for cardio-metabolic variables (blood pressure, blood glucose, lipid levels and cholesterol) with the hypothesis that greater adjustment may be associated with a lower effect estimate of physical activity on all-cause mortality. To investigate (iv) the robustness we investigated if effects were sensitive to the exclusion of deaths that occurred soon after collection of baseline data, the exclusion of non-brisk walking and to the quality of the studies. Finally, (v) we investigated if the effect varied by age, sex, or year of study by stratifying our analyses by these variables. For each stratified variable, if individual studies reporting stratified results by that variable were identified then we meta-analysed only that subset of studies. All analyses were conducted using Stata, release 10 (StataCorp, College Station, TX, USA). All statistical tests were 2-sided. 
Results
Search results
We retrieved 6210 records. Initial screening of title and abstract excluded 5725, see Figure 1 . No additional reports were retrieved from searching reference lists. We identified one additional report from personal communication. 18 We retrieved 42 reports for further inspection. We excluded 13 reports on examination of full text, including three for not assessing the exposure and outcome in at least 10,000 participants, 19-23 five for not providing an estimate for non-vigorous activity [24] [25] [26] [27] [28] , three for not reporting on all-cause mortality [29] [30] [31] , and one for only comparing two exposure levels 32 . Contact with one author produced additional data on hazard ratios for physical activity categories.
6 Table 1 presents the characteristics of the 22 independent studies 3-6, 33-51 reported in 30 reports. 18, [52] [53] [54] [55] [56] [57] [58] The studies included nearly 1 million participants (977,925), with more women (643,187) than men (334, 738) . The cohort studies were conducted in Europe (8 studies), North America (8 studies), East Asia (5 studies), and Australasia (1 study) with the most recent report for each study being published between 1996 and 2009. The studies covered a broad range of populations of middle and older age but younger adults were under represented, see Table 1 . Mean age at baseline ranged from 38 48 to 72
41
. Estimated exposure in the studies and the associated relative risks and CIs are presented in web only Table 2 .
Quality
Out of a maximum of 9 stars, we found that the median and mean number of stars awarded to a study was 6. The highest score was 8 stars (2 studies 3, 37 ) and the lowest score was 4 stars (3 studies 40, [50] [51] ) ( Table 3 ).
The majority of the included studies were of the general population of men or women from a geographically defined area 3-6, 33-39, 59-60 and all selected controls from the same population. Most studies excluded or adjusted on the basis of self reported health status, rather than clinical assessment. All studies controlled for smoking, using variables ranging from a simple yes or no question on current smoking status (7 studies 3, 33, 38, [40] [41] [50] [51] ) to current smoking status plus pack years 4, 6, 48 . Three studies presented equivalent data suitable for inclusion both with and without exclusion of deaths in the first years. 33, 43, 50 Four studies only provided suitable data after excluding deaths that occurred soon after measurement of baseline data 6, 40, 46, 48 , four studies said excluding such deaths did not substantially alter the effect estimate but did not provide the numbers. 4, 36, [38] [39] . Six studies adjusted for physical activity in other domains. 34-35, 38-39, 44, 47 
Assessment of physical activity
The studies used a range of methods to assess and then to combine physical activity (Table  4) . Four studies 3, 33, 38, 41 used an interview, while the rest used a self-completed questionnaire. Only one study included a repeat assessment of physical activity.
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Of the included studies most looked at time or frequency of bouts of activity but three studies estimated total MET hours over 24 hrs 3, 6, 40 , three presented results on walking alone 34, 38, 47 , two on active commuting [44] [45] , two on cycling alone 34, 38 , one on walking and cycling combined 34 and 11 included different kinds of activities measured by duration, frequency and intensity 4-5, 33, 36-37, 40-41, 44, 47-48, 50-51, 61 . All but one 33 specifically mentioned walking (recorded as either transport, work or leisure). One study excluded non-brisk , one study only included 'long walks' 50 and one study only included sessions of activity of a least 30 minutes. Most studies specifically included cycling as a moderate intensity activity.
For all studies the median exposure in each category had to be estimated. In 20 studies the highest exposure category was defined as greater than a given value, with only two studies providing more information. [48] [49] The highest exposure in our dataset was estimated to be 145 MET hours/wk (equating to 32 hours of moderate activity).
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Effect of non-vigorous physical activity on all-cause mortality
We first assessed possible non-linearity between non-vigorous physical activity as measured in MET-hours per week and all-cause mortality risk. We found that the power 0. Compared with inactive (0 MET-hours/week) individuals 11 MET hours of non-vigorous physical activity per week (about 2.5 hours per week) of moderate physical activity was associated with a 19% reduction in the mortality rate (95% CI 15 to 24%, heterogeneity Q = 196.77, I-squared= 85.8%). Compared with inactive individuals 31 MET hours per week, about 7 hours per week of light and moderate activity, was associated with 22% (95% CI 17 to 26%) and 24% (95% CI 19 to 29%) lower mortality rates respectively (see web-only Table  5 ).
Only three 41, [44] [45] out of the 29 sets of relative risks arising from 22 studies did not find a trend towards lower mortality with increased physical activity (Figure 3 ). The Egger's regression asymmetry test did not detect strong evidence of publication bias or small-study effects (P=0.053), as shown in the funnel plot in Figure 4 . In their most comprehensive assessment of physical activity, four studies provided estimates of exposure higher than 67.5 MET hours (equivalent to 15 h/wk of moderate intensity activity) 3, 35, 38, 40 and three of these studies found increasing benefit at all levels of energy expenditure.
Walking and cycling
We identified five studies that provided estimates based on walking exposure alone 34, 38, 43, [46] [47] , and one that measured walking and standing time. 35 In the assessment of possible nonlinearity, we found that the power 0.375 model for walking as measured in MET hours per week, presented graphically in Figure 5 Compared with no walking per week, 2.5 hour of brisk walking per week (approximately 11 MET hours per week) was associated with a RR=0.89 (95% CI 0.82 to 0.96). Even among the estimates that of walking alone there remained considerable heterogeneity (Q = 15.85, Pheterogeneity = 0.003, I-squared 74.8%), see Figure 6 .
The study of walking and standing found a similar effect to the studies specifically on walking (results not shown) 35 . The two studies that provided estimates based on active commuting alone (excluding walking and cycling for other reasons) [44] [45] 
Subgroup/Sensitivity analyses
In all the following subgroup and sensitivity analyses we fitted a power 0.25 transformation of the exposure variable. We found a larger effect in those studies that adjusted for more metabolic variables compared with those that adjusted for fewer metabolic variables (11 MET hours per week RR 0.79 vs RR 0.83).
We found that excluding deaths that occurred soon after measurement of baseline data randomisation had little effect on the results 33, 43, 50 (11 MET hours/wk RR 0.72 excluding early deaths vs RR 0.73 not excluding early deaths). We found a larger benefit in the higher quality studies (11 MET hours p/wk RR 0.80 studies with>=6 stars vs RR 0.83 studies with <6 stars). In one large study 39 a minimum threshold of moderate activity was set, excluding nonbrisk walking and other light activities. In one other study only 'long walks' were included.
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Excluding these studies did not change the size of the effect (11 MET hours/wk RR 0.81).
We next investigated if there was evidence of a difference in effect between men and women, using the seven studies that presented separate estimates for both sexes. We found a slightly larger effect in women than in men (11 MET hours/wk RR 0.85 for men and 0.83 for women). The effect in the group of studies that presented separate results by sex was smaller than in the overall analysis. We found little difference between the older studies compared with more recent studies (mid-year of study pre 1991 RR 0.80 vs, mid-year of study post 1990 RR 0.81). We found a larger reduction in mortality from lower physical activity doses in adults aged 65 years and older (11 MET hours/wk RR 0.78 for older adults vs 0.81 for younger adults).
DISCUSSION
In the meta-analysis we found an inverse association between physical activity (measured as MET hours) and the risk for all-cause mortality. This study is the first systematic review to estimate the dose response effect of non-vigorous intensity physical activity on all cause mortality. Based on these findings, in populations with low levels of activity 2.5 hours per week of moderate intensity activity would reduce mortality by 19%. Increasing this to one hour session seven days a week (7 hours per week) of activity could increase the benefit to 24%. Evidence on the dose response function allows estimation of the marginal benefits for groups with different levels of activity. Our analysis suggests a non-linear relationship with the greatest benefit appearing in the process of changing from a sedentary lifestyle to low levels of activity and smaller additional benefits from higher levels of activity. We found that walking reduces all-cause mortality but the effect was smaller than in studies that looked across activities in different domains.
Strengths and weaknesses
This systematic review benefits from the inclusion of large recently published cohort studies, 3, 6, [33] [34] [35] [36] in total representing nearly 1 million people. We sought unbiased estimates from large studies and were not short of power for the overall analysis. The analyses included study populations from Europe, North America, East Asia and Australasia. However, the studies were highly heterogeneous in their methods and their findings.
There are a number of factors that may have led to us over or under estimating the dose response relationship. Reasons for over-estimating the effect include any remaining Table 1 ) there are likely to remain potentially important confounding differences (such as in dietary factors) between people with higher and lower levels of physical activity that could substantially affect the results. Reasons for under-estimating the effect include the exclusion of people with existing disease, which might have been caused by lack of activity, and misclassification of exposure, both at baseline and over time. Previous research has found a low to moderate correlation between self reported and objectively measured physical activity, 62 and a larger effect on allcause mortality from objectively measured physical fitness than recalled physical activity.
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There is also a high probability of unrecorded change in exposure over time, given the length of follow up (25 year in the longest study 45 ) and the lack of repeat measures of exposure. These issues might not just affect the strength of association observed but also the shape of the dose response relationship. The small difference in the AIC result between the 0.25 power transformation and the 0.375 power exposure transformation models, further limits our confidence in the precise nature of the relationship.
Surprisingly, we found a larger effect in those studies that adjusted for more cardiometabolic at baseline. This finding could indicate that the benefits of physical activity on mortality occur largely independent of the effect on metabolic variables. However, there could be confounding at the study level. We only found a slightly larger effect in women than among men. This contrasts with a previous systematic review that found a notably larger effect in women. 63 Compared with this review our meta-analysis had the strength of only including studies that reported stratified results for men and for women, which should reduce the impact of study level confounding.
Effect estimates from previous reviews
A recent systematic review (search date 2007) and meta-analysis, including studies with more than 5000 people, found a 29% reduction in all cause mortality from self-reported physical activity, between the least and most active groups. 63 This review did not suggest the shape of the dose response relationship. An earlier review proposed an inverse linear dose response across studies but did not undertake a meta-analysis.
64 It suggested energy expenditure of about 4200 kilojoules per week would reduce mortality by 20 to 30%. A more recent review reporting median results suggested a curvilinear relationship. 65 It found an approximate reduction of 20% in the risk of all cause mortality from 1.5 hours per week of moderate to vigorous activity, and a further 20% reduction for 7 hours of activity. Our results suggest a smaller benefit and a more clearly non-linear relationship than that identified by these earlier reviews. It is possible these differences could be explained because the earlier reviews included smaller studies which found a larger effect. Alternatively our selection of point estimates specifically relating to non-vigorous activities of daily living may have led to a smaller effect estimate.
Walking and cycling
We found a smaller effect in those studies that included walking alone. If the people in the walking studies were active in other domains then this smaller effect would be expected with a non-linear relationship between total physical activity and all-cause mortality. However, it could be the case that even within light and moderate activities, activities of greater intensity than walking may bring additional benefit beyond the increase in MET hours. Furthermore, our confidence in the exact nature of the exposure response relationship between walking and mortality is limited by the small differences in the AIC between the different exposure transformations. 66 looked at walking and all-cause mortality. It reported a 20% risk reduction for an estimated exposure approximately equivalent to 3 hours per week at 3 km per hour. This is notably larger than our observed association. However, their analysis combined results from studies comparing different walking speeds as well as different walking durations or distances.
We found limited evidence on cycling. Estimates from both the Matthews 38 study from China, which found a large effect, and the Besson study from England 34 , which found no evidence of an effect, both came with considerable statistical uncertainty. The two studies of active commuting did not find evidence of an effect in men. [44] [45] In the first study, the lack of association might be partly explained by the high levels of work related activity amongst the study population. In the second study, the length of follow up, at 25 years, may have led to a high degree of misclassification of exposure over time. Cycling is usually categorised as more vigorous than walking 8 and, until more robust evidence is available, it may be reasonable to assume the benefit is similar to the overall benefit from moderate intensity activity, if applied to a given baseline level of activity.
Future research
Further research should investigate how different approaches to increasing one domain (such as walking) impacts on activities in other domains (such as leisure activity) and on other health behaviours, in particular diet and smoking.
The finding of a strongly non-linear relationship means that estimates of additional benefit from increasing activity will be strongly sensitive to assumptions on baseline activity levels. Health promotion recommendations for increasing moderate physical activity are primarily targeted at populations with low levels of vigorous activity. Although many of the studies included in our meta-analysis adjusted for vigorous activity, only one study 5 presented stratified results for people engaging and not engaging in vigorous physical activity. We recommend that future cohort investigators provide analyses stratified by time spent in vigorous activity, in addition to providing estimates controlling for other kinds of activity.
We recommend standardising measures of physical activity, the most promising measure being the International Physical Activity Questionnaire. 67 We encourage cohort investigators 7 to report the information required for meta-analysis of the dose response; in particular reporting the median exposure dose for each exposure interval not just the range.
Conclusion
Our systematic review and meta-analysis shows that non-vigorous physical activity has a dose-response protection effect against all cause mortality. The largest benefit was found in moving from sedentary behaviour to low levels of activity, but even at high levels of activity benefits accrue from additional activity. Records excluded on second appraisal: not assessing the exposure and outcome in at least 10,000 participants (n=77), not providing an estimate for non-vigorous activity (n=88), not reporting on all-cause mortality (n=110), wrong population (n=8), review or discussion paper (n=158)
Records retrieved for second appraisal: 485
Reports excluded on detailed examination: not assessing the exposure and outcome in at least 10,000 participants (n=5), not providing an estimate for non-vigorous activity (n=5), not reporting on all-cause mortality (n=3), wrong population (n=9), only providing two exposure categories (n=1), and multiple publication of study (n=9),
Records excluded on first appraisal of title and abstract: not related to physical activity or outcome of interest (n=5725) 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 peer-00608719, version 1 -14 Jul 2011 .7 1 1.5 2 Figure 3 . Adjusted relative risk of all-cause mortality for 11 vs 0 MET-hours/week of moderate non-vigorous physical activity.
CI indicates confidence interval. The size of each square is proportional to the study's weight (inverse of variance). Data were fitted with a random-effect model including a power transformation of 0.25 for nonvigorous physical activity (Q=196.77, p-value < 0.001, I-squared=86%). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 .7 1 1.5 2 Figure 6 . Adjusted relative risk of all-cause mortality for 11 vs 0 MET-hours/week of walking.
CI indicates confidence interval. The size of each square is proportional to the study's weight (inverse of variance). Data were fitted with a random-effect model including a power transformation of 0.375 for walking MET-hours/week (Q=15.85, p-value = 0.003, I-squared=75%). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
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